首页> 外文期刊>Peritoneal dialysis international: Journal of the International Society for Peritoneal Dialysis >Peritoneal dialysis retardation of progression of advanced renal failure.
【24h】

Peritoneal dialysis retardation of progression of advanced renal failure.

机译:腹膜透析延迟晚期肾功能衰竭的进展。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVES: The rate of decline of residual renal function is slower in peritoneal dialysis (PD) than in hemodialysis. However, it is unclear which and whether either of the two techniques modifies the natural course of renal failure. We tested whether PD influences the natural course of the progression of chronic renal failure in humans. DESIGN: Retrospective review of clinical charts. SETTING: Tertiary-care center. PATIENTS: Fourteen patients were selected from the 36 patients that were treated with PD in our center from January 1997 to June 2000, applying the following criteria: predialysis follow-up longer than 12 months, renal creatinine clearance 20 mL/minute or more at the start of predialysis follow-up, follow-up while on PD longer than 6 months, and renal creatinine clearance above 0 mL/minute at the start of PD. MAIN OUTCOME MEASURE: Residual renal function calculated as renal creatinine clearance obtained from 24-hour urine samples. RESULTS: A lower mean rate of decline of residual renal function was observed during PD than during the predialysis period (-0.06 +/- 0.16 vs -0.94 +/- 0.74 mL/min/month, p < 0.0005). The rate of decline in renal creatinine clearance was faster in every patient during the predialysis period than during his or her time on PD. CONCLUSIONS: These preliminary data support the hypothesis that PD may contribute to the slowing of the natural progression of renal disease in humans, as it does in rodents. Prospective studies involving a larger number of patients are needed to settle the question.
机译:目的:腹膜透析(PD)的残余肾功能下降速率比血液透析慢。但是,尚不清楚这两种技术中的哪一种以及是否能改变肾衰竭的自然病程。我们测试了PD是否会影响人类慢性肾衰竭进展的自然过程。设计:回顾性临床图表。地点:三级护理中心。患者:从1997年1月至2000年6月在我们中心接受PD治疗的36例患者中,选择14例患者,应用以下标准:透析前随访时间超过12个月,肾肌酐清除率在20 mL / min或以上。开始透析前的随访,PD随访超过6个月,PD开始时肾肌酐清除率高于0 mL / min。主要观察指标:残余肾功能计算为从24小时尿液样本中获得的肾肌酐清除率。结果:与透析前相比,PD期间残余肾功能的平均下降速率更低(-0.06 +/- 0.16 vs -0.94 +/- 0.74 mL / min /月,p <0.0005)。在透析前期,每位患者的肾肌酐清除率下降速度都比其在PD期间要快。结论:这些初步数据支持以下假设:PD可能会像啮齿动物一样导致人类肾脏疾病自然进程的减慢。需要解决涉及大量患者的前瞻性研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号